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Abstract Transgenic (TG) Ca
2?/calmodulin-dependent
protein kinase II (CaMKII) dC mice develop systolic heart
failure (HF). CaMKII regulates intracellular Ca
2? handling
proteins as well as sarcolemmal Na
? channels. We
hypothesized that CaMKII also contributes to diastolic
dysfunction and arrhythmias via augmentation of the late
Na
? current (late INa) in early HF (8-week-old TG mice).
Echocardiography revealed severe diastolic dysfunction in
addition to decreased systolic ejection fraction. Premature
arrhythmogenic contractions (PACs) in isolated isometri-
cally twitching papillary muscles only occurred in TG
preparations (5 vs. 0, P\0.05) which could be completely
terminated when treated with the late INa inhibitor ranol-
azine (Ran, 5 lmol/L). Force–frequency relationships
revealed signiﬁcantly reduced twitch force amplitudes in
TG papillary muscles. Most importantly, diastolic tension
increased with raising frequencies to a greater extent in TG
papillary muscles compared to WT specimen (at 10 Hz:
3.7 ± 0.4 vs. 2.5 ± 0.3 mN/mm
2; P\0.05). Addition of
Ran improved diastolic dysfunction to 2.1 ± 0.2 mN/mm
2
(at 10 Hz; P\0.05) without negative inotropic effects.
Mechanistically, the late INa was markedly elevated in
myocytes isolated from TG mice and could be completely
reversed by Ran. In conclusion, our results show for the
ﬁrst time that TG CaMKIIdC overexpression induces dia-
stolic dysfunction and arrhythmogenic triggers possibly via
an enhanced late INa. Inhibition of elevated late INa had
beneﬁcial effects on arrhythmias as well as diastolic
function in papillary muscles from CaMKIIdC TG mice.
Thus, late INa inhibition appears to be a promising option
for diastolic dysfunction and arrhythmias in HF where
CaMKII is found to be increased.
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Introduction
Systolic contractile dysfunction in heart failure (HF) is
caused by altered intracellular ion homeostasis and struc-
tural remodeling. Several pathomechanisms have been
identiﬁed. The sarcoplasmic reticulum (SR) Ca
2?-ATPase
(SERCA) protein levels and its activity are reduced in
parallel to a diminished SR Ca
2?-uptake capacity in the
failing heart [8, 9, 19, 22]. The functional consequence is
an impaired SR Ca
2?-loading leading to smaller intracel-
lular Ca
2? transients and elevated diastolic Ca
2? levels [3].
Ca
2? homeostasis is further regulated by phosphorylation
of several key proteins thereby controlling Ca
2?- as well as
Na
?-ﬂuxes in hypertrophy [13] and HF [15]. In this con-
text, the Ca
2?/calmodulin-dependent protein kinase II
(CaMKII) is of major importance [15]. The predominant
cardiac isoform is CaMKIId with the splice variant dC
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DOI 10.1007/s00395-010-0136-xbeing primarily cytosolic [32]. CaMKII is a serine/threo-
nine protein kinase that modulates several Ca
2?-dependent
proteins, such as SR Ca
2?-release channels (ryanodine
receptors, RyR2), phospholamban (PLB) which regulates
SERCA and L-type Ca
2?-channels.
We and others have recently shown that CaMKIId also
regulates Na
? channels in myocytes, most likely by asso-
ciation with and phosphorylation of sarcolemmal Na
?
channels [1, 31]. Overexpression of CaMKIId was associ-
ated with an enhanced late INa that inactivates with much
slower kinetics [31]. Although the amplitude of this current
is very small compared to peak INa, the slow inactivation
kinetic results in a substantial Na
? entry during the action
potential (AP) leading to a signiﬁcant prolongation of the
AP duration [7, 24].
There is strong evidence for an increased late INa in
ventricular myocytes and its contribution to HF via
[Na
?]i elevation [5, 18, 20, 29]. Mechanistically, aug-
mentation of the late INa plays a crucial role in impaired
contractility and repolarization of the failing myocardium
[17, 29]. We have recently shown that an increased late
INa can substantially elevate intracellular Na
? and con-
sequently diastolic Ca
2? via reverse mode of the Na
?/
Ca
2?-exchanger (NCX) leading to diastolic dysfunction
in isolated human ventricular end-stage failing myocar-
dium [24].
Furthermore, it is well accepted that an increased late
INa is known to produce arrhythmogenic triggers, such as
early afterdepolarizations (EADs) via prolongation of the
cardiac AP or delayed afterdepolarizations (DADs) caused
by a Na
?-dependent diastolic Ca
2? overload and oscilla-
tory SR Ca
2?-release which may activate a transient
inward current (ITi)[ 14, 17, 23].
We have recently shown that pharmacological inhibition
of CaMKII reduces cellular proarrhythmogenic events and
decreases arrhythmias in vivo in TG CaMKIIdC mice with
severe HF due to reduced spontaneous SR Ca
2? release
events (Ca
2? sparks) [21]. We hypothesized that CaMKII-
dependent late INa augmentation is a novel cause for dia-
stolic dysfunction and arrhythmias in CaMKII TG mice
with non-ischemic compensated HF.
Methods
CaMKIIdC transgenic mice
CaMKIIdC transgenic (TG) mice were generated using an
a-MHC promoter as previously described [33]. We used
8-week-old CaMKIIdC-TG mice and age- and sex-matched
WT littermates. All animal studies were approved by the
Ethics Committee of the Medical Faculty of the University
of Go ¨ttingen.
Transthoracic echocardiography
Transthoracic echocardiography was performed using a
Vevo2100 (VisualSonics, Toronto, Canada) system with a
30 MHz center frequency transducer. Brieﬂy, animals
were anesthetized with 3% isoﬂurane, and temperature-,
respiration-, and ECG-controlled anesthesia was main-
tained with 1.5% isoﬂurane. Two-dimensional cine loops
with frame rates of[200 frames/s of a long-axis view and
a short-axis view at mid-level of the papillary muscles as
well as M-mode loops of the short-axis view were
recorded. Thicknesses of the anterior myocardial wall
(AWTh), the posterior myocardial wall (PWTh), the inner
diameter of the left ventricle (LVID) and the area of the
left ventricular cavity (Area) were measured in systole
and diastole from the short-axis view according to stan-
dard procedures [4]. Maximal left ventricular length was
measured from the long-axis view. Systolic and diastolic
left ventricular volumes were calculated using the area–
length method. Maximal diastolic radial velocity of the
anterior wall was analyzed using the VevoStrain software
(VisualSonics, Toronto, Canada). Measurements were
obtained by an examiner blinded to the genotype of the
animals.
Mouse intact papillary muscle preparation
TG mice were anesthetized using isoﬂurane. Hearts were
rapidly excised and retrogradely perfused with a modiﬁed
Krebs–Henseleit buffer solution containing (in mmol/L)
Na
? 140.5, K
? 5.1, Mg
2? 1.2, Ca
2? 0.25, Cl
- 124.9,
SO4
2- 1.2, PO4
3- 2.0, HCO3
- 20, glucose 10, and
butanedione monoxime (BDM) 20, equilibrated with
carbogen (95% O2,5 %C O 2, pH 7.4). Intact papillary
muscles were isolated from the RV wall using a stereo-
scopic microscope in a dissection chamber. Cross-sectional
dimensions were similar in WT as well as TG mice
(width 9 thickness 9 p/4, 0.22 ± 0.01 mm
2 for TG and
0.16 ± 0.07 mm
2 for WT, P = 0.3).
Characterization of contractile phenotype
For isometric force recordings, papillary muscles were
mounted in an organ chamber and connected to the force
transducer (Scientiﬁc Instruments, Heidelberg, Germany).
Papillary muscles were superfused with Krebs–Henseleit
solution (in mmol/L: NaCl2 116, KCL 5, NaH2PO4 2,
MgCl2 1.2, Na2SO4 1.2, NaHCO3 20, CaCl2 initially 0.25;
end concentration 1.25, glucose 10) that was also oxy-
genated with 95% O2 and 5% CO2 (37C). Isometric
contractions were elicited using electrical ﬁeld stimulation
with a basal stimulation frequency of 4 Hz (voltage 25%
above threshold, normally 3–5 V, stimulator, Scientiﬁc
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2? (0.25 mmol/L)
was added every 2 min after a 30 min washout phase until
the ﬁnal concentration of 1.25 mmol/L was reached in
order to prevent a Ca
2?-induced contracture. After an
equilibration period of 20 min, the muscles were gradually
stretched until the maximum steady-state twitch force was
achieved and 5 lmol/L ranolazine (Ran, Gilead, Palo Alto,
USA) or vehicle was added to the bath solution. After
having characterized the basal effect of late INa inhibition,
force–frequency relationships were obtained using
increasingly higher stimulation rates of 2, 4, 6, 8, 10, and
then back to 4 Hz. To measure SR Ca
2?-load, post-rest
behavior was assessed by using increasing rest intervals of
5 and 10 s between beats at a basal stimulation frequency
of 4 Hz [24, 26]. Short periods of rest increase force of
contraction of the ﬁrst beat upon restimulation which is
considered to be dependent on SR Ca
2?-uptake and release
[25]. In addition, persistent premature arrhythmogenic
contractions (PACs) were assessed [26]. PACs had to be
stable and to persist continuously over 5 min before the
effect of Ran was evaluated [26].
Patch-clamp experiments
Ruptured-patch whole-cell voltage-clamp was used to
measure INa as described previously [24, 26]. Microelec-
trodes (2–3 MX) were ﬁlled with (mmol/L) 40 CsCl, 80
Cs-glutamate, 10 NaCl, 0.92 MgCl2, 5 Mg-ATP, 0.3
Li-GTP, 10 HEPES, 0.03 niﬂumic acid, 0.02 nifedipine,
0.004 strophanthidin, 5 BAPTA (tetracesium salt), 1 5,50-
dibromo BAPTA (tetrapotassium salt), 1.49 CaCl2 (free
[Ca
2?]i = 100 nmol/L; pH 7.2, CsOH). The bath solution
contained (mmol/L) 130 NaCl, 10 tetraethylammonium
chloride, 4 CsCl, 1 MgCl2, 10 glucose, 10 HEPES, (pH 7.4,
NaOH). Myocytes were mounted on the stage of a micro-
scope (Nikon Eclipse TE2000-U, Du ¨sseldorf, Germany).
Fast capacitance which is generated largely by the pipette
itself was compensated in cell-attached conﬁguration.
Liquid junction potentials (3–6 mV) were corrected.
Membrane capacitance was compensated after patch rup-
ture, access resistance was typically \7M X. All record-
ings were started 5 min after rupture. Signals were ﬁltered
with 2.9 and 10 kHz Bessel ﬁlters and recorded with an
EPC10 ampliﬁer (HEKA Elektronik Dr. Schulze GmbH,
Lambrecht/Pfalz, Germany). Myocytes were held at
-120 mV and late INa was elicited using 250 ms depo-
larizing pulses to -30 mV. Each pulse was preceded by a
5 ms pre-pulse to ?50 mV in order to optimize voltage
control. The measured currents were normalized to the
membrane capacitance. INa decay (ﬁrst 200 ms) was ﬁtted
using a double exponential function y(t) = A1 exp (–t/s1) ?
A2 exp (–t/s2) ? y0. All patch-clamp experiments were
conducted at room temperature.
Western blots
Myocardium was homogenized in Tris buffer containing in
mmol/L: 20 Tris–HCl, pH 7.4, 200 NaCl, 20 NaF, 1
Na3VO4, 1 DTT, 1% Triton X-100 and complete protease
inhibitor cocktail (Roche Diagnostics, Grenzach-Wyhlen,
Germany). Protein concentration was determined by BCA
assay (Pierce Biotechnology, Rockford, USA). For NCX,
denatured cell lysates and tissue homogenates (on ice in 2%
beta-mercaptoethanol) were subjected to Western blotting
(8% SDS-polyacrylamide gels) using anti-NCX (1:5000;
Swant, Bellinzona, Switzerland), anti-GAPDH (1:40,000,
Biotrend Chemikalien GmbH, Ko ¨ln, Germany) as primary
and an HRP-conjugated donkey anti-rabbit and sheep anti-
mouse IgG (1:10,000; Amersham Biosciences, Freiburg,
Germany) as secondary antibody. SERCA blots were per-
formed using denatured cell lysates and tissue homogenates
(on ice in 2% beta-mercaptoethanol) which were subjected
to Western blotting (8% SDS-polyacrylamide gels) using
anti-SERCA2 (1:20,000; Afﬁnity BioReagents, Rockford,
USA) and anti-GAPDH (1:40,000, Biotrend Chemikalien
GmbH, Ko ¨ln, Germany) as primary and an sheep anti-
mouse IgG (1:10,000; Amersham Biosciences, Freiburg,
Germany) as secondary antibody. Chemiluminescent
detection was done with Immobilion Western Chemilumi-
nescent HRP Substrate (Millipore, Billerica, USA).
Data analysis and statistics
Force values were normalized to the cross-sectional area of
each muscle (width 9 thickness 9 p/4) and expressed in
mN/mm
2. All data are shown as mean ± S.E.M. Student’s
t test, 2-way or 1-way repeated measures ANOVA with
post hoc tests or Fisher‘s exact test were used to test for
signiﬁcance. A two-sided P value of\0.05 was considered
signiﬁcant.
Results
Cardiac phenotype of transgenic CaMKIIdC mice
In CaMKIIdC TG mice the heart weight/body weight ratio
was increased by *40% as compared to WT (Fig. 1a–c,
n = 13 vs. 14, P\0.05) indicating an early stage of
hypertrophy (8-week-old mice) since this value canincrease
to more than twofold in 3-month-old mice [16]. Figure 1d
shows original M-mode echocardiographic recordings with
ventricularsystolicdysfunctioninaTGascomparedtoaWT
mouse. TG mice have a reduced fractional area shortening
(Fig. 1e) as well as a reduced ejection fraction of 27 ± 1%
compared to 50 ± 5% in WT mice (Fig. 1f, n = 5 each,
P\0.05). In order to evaluate diastolic function the
Basic Res Cardiol (2011) 106:263–272 265
123relaxation velocity was also determined. TG CaMKIIdC
mice had markedly impaired relaxation velocities of
1.0 ± 0.4 cm/s compared to 2.3 ± 0.2 cm/s in WT mice
(Fig. 1g, P\0.05). Therefore, these mice suffer from dia-
stolic in addition to systolic dysfunction.
Changes in Ca
2? handling proteins
We investigated SERCA and NCX protein abundance in
WT and CaMKIIdC TG left ventricular myocardium to
assess their possible involvement in the alterations of dia-
stolic left ventricular performance. We found that SERCA
protein levels were reduced to 74 ± 10% in TG CaMKIIdC
mice (Fig. 2a, n = 7 vs. 6 WT, P\0.05), while NCX
protein abundance was unaltered (Fig. 2b). Here, it is
important to note that NCX protein levels in 3-month-old
TG CaMKIIdC mice, a time where these mice develop
overt HF, are dramatically increased [16].
Premature contractions in isolated papillary muscles
While muscles from WT mice did not develop PACs [26]
we found PACs in all investigated TG muscles (n = 5;
P\0.05, Fisher0s test, Fig. 3a, b). Addition of vehicle
solution did not terminate PACs, whereas these were
inhibited by adding 5 lmol/L Ran to the bath solution
(Fig. 3c, d, P\0.05, Fisher0s test). These antiarrhythmic
effects of Ran were observed within 2 min of exposure to
the drug. Thereafter, the papillary muscles remained stable
and generated a regular rhythmic stimulation-dependent
response.
Basal contractility
Inanother seriesofexperimentsthebasaleffectof5 lmol/L
Ran was investigated in TG muscles stimulated at 4 Hz.
After an incubation period of 15 min twitch force amplitude
was81.1 ± 6.3%(normalizedtobaseline)invehicle-treated
specimen as compared to 69.3 ± 6.7% (n = 9 each,
P = 0.22, data not shown) in the presence of 5 lmol/L Ran.
While force amplitude was unchanged we found a reduced
diastolic tension in Ran-treated muscles to 87.0 ± 2.8%
as compared to vehicle with 99.6 ± 5.5% (P\0.05,
Fig. 4a).
Post-rest behavior of papillary muscles was determined
at rest intervals of 5 and 10 s to biomechanically assess SR
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Fig. 1 Cardiac phenotype
characteristics. a Heart weight
of TG CaMKIIdc mice was
increased compared to WT
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266 Basic Res Cardiol (2011) 106:263–272
123Ca
2? content [24, 26]. Figure 4b summarizes these results
indicating that SR function is impaired in specimen from
TG mice while addition of Ran had no further effect on
post-rest behavior. At 10 s of rest the ﬁrst twitch after rest
divided by the last before rest (pr/ss) was 2.7 ± 0.5 in WT
muscles and was reduced in specimen from TG mice to
1.6 ± 0.2 (Fig. 4b, n = 7 each, P\0.05). Ran did not
affect post-rest behavior in TG papillary muscle (Fig. 4b).
Contractile response at increasing stimulation
frequencies
In order to determine the effect of Ran on contractile
function, we obtained force–frequency relationships in
muscles stimulated at frequencies up to 10 Hz (Fig. 5a).
TG papillary muscles presented with lower baseline force
compared to WT and a negative staircase phenomenon
(RM-ANOVA P\0.05, WT vs. TG: n = 10 vs. 11;
Fig. 5b). In a second series of experiments, TG papillary
muscles were treated with 5 lmol/L Ran. This intervention
had no effect on twitch force amplitude in TG muscles
(n = 11, RM-ANOVA P = 0.6; Fig. 5b).
In contrast, the TG muscles developed a constant
increase in diastolic tension up to 3.7 ± 0.4 mN/mm
2
compared to WT specimen with 2.5 ± 0.2 mN/mm
2
(n = 11 vs. 10, RM-ANOVA P\0.05), which we inter-
pret as an ex vivo presentation of diastolic dysfunction.
This effect was more pronounced at higher stimulation
frequencies. Ran normalized diastolic tension markedly to
2.3 ± 0.3 mN/mm
2 (n = 11, RM-ANOVA P\0.05). Of
note, there was no signiﬁcant reduction of diastolic tension
in WT specimen in the presence of Ran (data not shown).
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123Measurements of the late Na
? current
The slow time constant (s2) of the double exponential
function which largely corresponds to late INa was pro-
longed in TG compared to WT myocytes at 0.5 Hz
(81.9 ± 8.3 vs. 37.6 ± 3.6 ms, n = 11 vs. 6, P\0.05,
Figs. 6a, b, Table 1). Interestingly, this prolongation of the
slow, second inactivation phase in TG could be reversed in
the presence of Ran (38.8 ± 4.1 ms, n = 7, P\0.05 vs.
vehicle), which is in accordance with substantial late INa
inhibition. In contrast, there was no signiﬁcant prolonga-
tion of fast INa decay in TG myocytes vs. WT littermates
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123(Table 1). Moreover, Ran also did not inﬂuence fast INa
decay kinetics.
Discussion
Here, we show for the ﬁrst time that 8-week-old TG
CaMKIIdC mice develop non-ischemic diastolic dysfunc-
tion in addition to systolic HF. In these mice, late INa was
markedly higher as compared to WT. Inhibition of late INa
in vitro using Ran led to a signiﬁcant improvement of dia-
stolic function without negative inotropic effects. Arrhyth-
mogenic events can be found in multicellular preparations
of TG CaMKIIdC mice even in the absence of isoprenaline.
Moreover, Ran shows antiarrhythmic effects even in the
absence of NCX upregulation. In summary, diastolic
dysfunction and arrhythmias share a similar molecular
mechanism by means of increased diastolic Na
?. Both
clinical problems may be approached by inhibiting late INa.
Cardiac overexpression of CaMKIIdC
CaMKIIdC overexpression was shown to be associated
with HF [32] and arrhythmias in vivo [21, 31]. CaMKII
activity is increased by *3-fold in TG CaMKIIdC mice
[33] which is similar to the increased CaMKII activity
observed in failing human hearts [11, 12].
To reduce complex remodeling caused by advanced HF
we investigated younger mice (8 weeks old); this is in clear
contrasttoearlierstudies[21,27,31].Interestingly,although
these mice are younger compared to those of other reports,
thesystoliccontractilefunctionofthemyocardiumisalready
severely depressed as evident by echocardiography. Muscle
experiments in vitro revealed impaired contractile force and
post-rest behavior. We found a decreased expression of
SERCA protein as a typical change that occurs in the failing
myocardium contributing to decreased SR Ca
2? content and
SRCa
2?release.Therefore,theTGCaMKIIdCmousecanbe
regarded as amodelof elevated CaMKIIactivity, butalso as
a pathophysiological relevant model of non-ischemic HF.
CaMKIIdC, late INa, and arrhythmias
In the present work, PACs only occurred in papillary
muscles isolated from TG CaMKIIdC mice, whereas no
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mice vs. WT (n = 11 vs. 6,
P\0.05). Addition of Ran
shortened this time constant in
myocytes from CaMKIIdcT G
mice consistent with substantial
late INa inhibition (n = 7,
P\0.05)
Table 1 Fit parameters (ms) for INa decay using a double exponential
function y(t) = A1 exp (–t/s1) ? A2 exp (–t/s2) ? y0
Group s1 s2
WT 3.7 ± 0.7 37.6 ± 3.6*
TG 6.1 ± 1.0 81.9 ± 8.3
TG ? Ran 5.0 ± 0.8 38.8 ± 4.1*
INa decay (ﬁrst 200 ms) was ﬁt for registrations at 0.5 Hz. Time
constant for slow INa decay s2 corresponding to the late phase of INa
decay (i.e. late INa) was increased in TG vs. both WT and TG ? Ran.
In contrast, fast INa decay represented by s1 was not signiﬁcantly
changed
* t Test and 1-way ANOVA with Dunnett0s post-test P\0.05 vs. TG
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123arrhythmias were observed in WT specimens. These results
are generally in line with our previous ﬁndings showing
that isoprenaline-induced EADs and DADs are associated
with CaMKIIdC overexpression [21]. Inhibition of CaMKII
in the previous report depressed EADs and DADs. More-
over, the current data add important information because
even without addition of isoprenaline arrhythmogenic
events can be found in muscles in vitro from CaMKIIdC
TG mice.
It was suggested previously that the SR Ca
2?-leak
would play an important role in this pathology [21].
Indeed, cardiomyocytes isolated from CaMKIIdC mice
have an increased open probability of the RyR leading to
increased SR Ca
2?-sparks and Ca
2?-oscillation which may
trigger ITi and arrhythmias [16, 21, 31].
However, in addition to SR Ca
2? leak, prolonged APs
[17] are also observed in these mice which may increase
the propensity for EADs. Late INa is known to prolong the
AP and thereby likely contribute to EADs [23]. Since
CaMKII was shown to regulate Na
? channels, it is possible
that this mechanism is also crucially involved in the
arrhythmogenesis observed. Hence, antiarrhythmic effects
of CaMKII inhibition may actually be mediated largely
through late INa.
Therefore, we tested whether inhibition of late INa using
Ran would lead to a similar reduction of the arrhythmic
propensity as described previously [22]. Ran has been
shown to selectively inhibit late INa vs. peak INa (especially
at concentrations of 5 lmol/L) [2] and we now show
indeed that Ran reduces late INa in TG myocytes. This is in
contrast to another study where CaMKII inhibition could
not reduce intracellular Na
? [32] (through late INa) and
may be explained by the fact that in the current report
young mice where used in which only a functional
upregulation of late INa may occur. In contrast in older
mice, several other mechanisms may be involved, such as
altered expression/trafﬁcking of Na
? channels, involve-
ment of other kinases activated during congestive HF, as
well as less altered local phosphatase binding/expression at
the Na
? channel (as reported for RyR).
Nevertheless, we found a strong effect of Ran on PACs
in CaMKIIdC specimen. This effect commonly occurred
within minutes and kept the preparation stable in a stimu-
lation-dependent rhythm. These results also indicate that
the late INa may play a crucial role in the arrhythmogenesis
in failing hearts and that blockade of late INa appears useful
to control HF associated arrhythmias.
Inhibition of late INa ameliorates diastolic dysfunction
Elevated diastolic Ca
2? as a consequence of reverse NCX
activity in Na
?-overloaded cardiomyocytes may on the one
hand cause arrhythmias and on the other hand also impair
diastolic contractile performance of the heart. Echocar-
diographic analyses conﬁrmed diastolic dysfunction in TG
CaMKIIdC mice. Moreover, in isometrically twitching
preparations we found a frequency-dependent increase in
diastolic tension compared to WT specimen which may be
an additional indication for increased diastolic Ca
2?.T h i s
may be at least partly explained by the ﬁnding that SERCA
protein is downregulated while NCX is still unchanged in
TG hearts isolated from 8-week-old mice, whereas older
mice (e.g. 3 months) exhibit increased NCX expression
levels [16]. Another possibility for elevated diastolic Ca
2?
levels (and thus altered mechanical function) may be a
slight albeit not signiﬁcant downregulation of calsequestrin
protein expression (data not shown). Calsequestrin is a
low-afﬁnity, high-capacity Ca
2?-binding protein in the SR
which is often used as a housekeeping gene. Therefore, we
preferred to normalize our Western blot results to GAPDH
which is unaltered. Nevertheless, we acknowledge that
even slight alterations of calsequestrin expression and
hence impaired SR Ca
2? storage capacity might be a
limitation with respect to the interpretation of our study but
the calsequestrin downregulation does not reach the extent
as shown in another study with a clear and signiﬁcant 20%
downregulation (vs. WT) when CaMKIIdc transgenic mice
were crossbred with RyR2R4496C mutated mice [6]. It is
important to note that to date neither multicellular tissue
nor cardiomyocytes isolated from TG CaMKIIdC mice
have been investigated at physiological heart rates (up to
10 Hz). Here, we show that diastolic tension increased at
6 Hz and above.
Wagner et al. have previously shown that overexpression
of CaMKIIdC results in an increase of [Na]i that could be
signiﬁcantly reduced by CaMKII-inhibitors in acute CaM-
KIIdC overexpressing myocytes [31]. However, a similar
increaseof[Na]icouldnotbereversedbyCaMKIIinhibition
in TG CaMKIIdC mice at 3 months of age suggesting that
there may be other sources of Na
? entry or CaMKII-inde-
pendent mechanism involved that may have to do with the
remodeling processes during HF progression. However,
sincelateINainhibitioncanshortentheAP,areducedreverse
mode NCX activity may be the consequence leading to less
Ca
2? overload and less diastolic dysfunction.
In the present work, we were interested whether inhi-
bition of elevated late INa in TG myocytes might improve
contractile function. Indeed, we found evidence for a
reduced diastolic dysfunction in the presence of Ran. This
effect could be observed under several conditions. Inter-
estingly, this effect was not paralleled by any negative
inotropy. The ﬁndings of our study are in agreement with
our previous report showing improved diastolic function
due to inhibition of late INa [24, 26, 28]. Most importantly,
in isolated human failing myocardium CaMKII and late INa
are markedly elevated [11, 12, 18, 31].
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123Our results indicate that the late INa plays a crucial role
in determining diastolic function. Inhibition of late INa may
counteract the CaMKII effect that induces elevation of this
current leading to Na
? overload of the cell. Moreover, the
fact that the Ran effect was pronounced at higher fre-
quencies supports that concept that AP shortening may be
an additional mechanism of Ran-dependent improvement
of diastolic function. Since diastolic dysfunction can be
induced by structural as well as electrical remodeling [10],
the sensitivity of TG myocardium to Ran and the acute
effect observed in our experiments shows that diastolic
function is strongly related to electrical remodeling.
However, there are also types of HF showing diastolic
dysfunction which depends mainly on ﬁbrosis [30].
Conclusions
Chronic overexpression of CaMKIIdC leads to diastolic and
systolic dysfunction as well as an increased propensity for
arrhythmias. Inhibition of an increased late INa in TG
myocardium was effective in treating diastolic dysfunction
and arrhythmias. Hence the relation between elevated
CaMKII activity and increased late INa in HF may be of
therapeutic interest and merits further investigation.
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